Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes.
Mulley, J. F.
Show abstract
Aims CGM devices report glucose only within fixed limits (typically 40-400 mg/dL; 2.2-22.2 mmol/L), truncating extreme values to a boundary ("capping"). We characterised prevalence, duration, and consequences of capping in type 1 diabetes trial data. Materials and Methods We analysed 46,990,617 CGM readings from 948 participants across four publicly available clinical trial datasets (Dexcom G4 Platinum or G6 sensors). Capping prevalence, run duration, and associations with age, HbA1c and sex were characterised across all datasets. In the 77 participants of the Replace-BG trial CGM-plus-blood glucose monitor (BGM) arm, CGM-derived metrics were compared with contemporaneous BGM measurements across 1,162 non-overlapping 14-day windows. Results Between 93.5% and 100% of participants had at least one capped reading, and capped values comprised 0.47-0.98% of all readings. In the three datasets for which duration could be calculated, over 70% of upper-cap runs exceeded 15 minutes and over one third exceeded 60 minutes. Upper-limit capping was inversely associated with age (Spearman {rho} -0.20 to -0.47, p[≤]0.002) in three of the datasets, and positively associated with baseline HbA1c ({rho} 0.39-0.62, p<0.001) in all four datasets. A within-participant analysis showed that capping burden did not predict CGM-BGM divergence in any summary metric (all p>0.2), and a systematic CGM-BGM offset in mean glucose and time in range (TIR) reflected the physiological lag between blood and interstitial fluid rather than capping artefact. Conclusions Sensor limit capping is near-universal in type 1 diabetes, produces sustained periods of right-censored glucose data disproportionately affecting younger patients, and does not substantially distort standard summary metrics at the population level. Clinicians and trialists should be aware that CGM data can confirm extreme glucose events but cannot quantify their severity.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Accounting for age-related increases in HbA1c more accurately quantifies risk of Type 1 Diabetes progression in islet autoantibody-positive adults 91%
- Poor in-utero growth, reduced beta cell secretion and high plasma glucose in childhood are harbingers of glucose intolerance in young Indians 91%
- The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk prediction 90%
Similar papers in this journal
- Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: an overview of the data from the epidemiological studies within the IMI DIRECT Consortium 92%
- Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes 91%
- Urinary metabolite profiling identifies biomarkers for risk of progression of diabetic nephropathy in 2,670 individuals with type 1 diabetes 90%
Similar papers in this journal
- Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population 92%
- Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes 90%
- Novel mediation analysis of human plasma proteome and metabolome reveals mediators of improved glycemia after gastric bypass surgery 90%
Similar papers in this journal
- Daily variation in blood glucose levels during continuous enteral nutrition in patients on the Intensive Care Unit: a retrospective observational study 92%
- Low-level mosaic variants causing the pancreatic disease congenital hyperinsulinism can be detected from blood DNA 91%
- Precision Diagnostic Approach to Predict 5-year Risk for Microvascular Complications in Type 1 Diabetes 91%
Similar papers in this journal
- Characterizing common and rare variations in non-traditional glycemic biomarkers using multivariate approaches on multi-ancestry ARIC study 90%
- Impacts of COVID-19 on glycemia and risk of diabetic ketoacidosis 89%
- Integrative proteogenomic analyses provide novel interpretations of type 1 diabetes risk loci through circulating proteins 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.